Also known as: Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal)
Highest phase reached
Phase 2
First clinical trial
Last known activity
Sep 1, 2017
No events for the selected filters.
Phase 2 (1 own, 0 via acquisition)
Studied for